NCT06788509 2026-04-13A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringJanssen Research & Development, LLCPhase 1 Enrolling by invitation120 enrolled
NCT04104776 2025-05-15A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasNovartisPhase 1/2 Recruiting275 enrolled